Biotransformation Reactions and Their Enzymes

The Practice of Medicinal Chemistry

Volumn , Issue , 2008, Pages 655-673

  Testa, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882486040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374194-3.00032-9     Document Type: Chapter

References (70)

1. Testa, B., Krämer, S.D. The biochemistry of drug metabolism. VHCA, Zurich, and Wiley-VCH, Weinheim; Vol. 1, 2008, pp. 319; Vol. 2, 2009, in press.
2. Timbrell J.A. Principles of Biochemical Toxicology 1991, Taylor & Francis, London. 2nd Edition.
3. Silverman R.B. The Organic Chemistry of Drug Design and Drug Action 2004, Academic Press, San Diego. 2nd Edition.
4. Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity 1994, Springer Verlag, Berlin. F.C. Kauffman (Ed.).
5. Pharmacokinetics of Drugs 1994, Springer, Heidelberg. P.G. Welling, L.P. Balant (Eds.).
6. Conjugation-Dependent Carcino-genicity and Toxicity of Foreign Compounds 1994, Academic Press, San Diego. M.W. Anders, W. Dekant (Eds.).
7. Testa B. The Metabolism of Drugs and Other Xenobiotics - Biochemistry of Redox Reactions 1995, Academic Press, London.
8. Cytochrome P450. Structure, Mecha-nism, and Biochemistry 1996, Plenum Press, New York. 2nd Edition. P.R. Ortiz de Montellano (Ed.).
9. Handbook of Drug Metabolism 1999, Dekker, New York. T.F. Woolf (Ed.).
10. Enzyme Systems that Metabolise Drugs and Other Xenobiotics 2002, Wiley, Chichester. C. Ioannides (Ed.).
11. Drug-Drug Interactions 2002, Dekker, New York. A.D. Rodrigues (Ed.).
12. Testa B., Mayer J.M. Hydrolysis in Drug and Prodrug Metabolism - Chemistry, Biochemistry and Enzymology 2003, Wiley-VHCA, Zurich.
13. Handbook of Drug-Nutrient Interactions 2004, Humana Press, Totowa, NJ. J. Boullata, V.T. Armenti (Eds.).
14. Drug Metabolism and Transport 2005, Humana Press, Totowa, NJ.
15. Cytochrome P450 Protocols 2006, Humana Press, Totowa, NJ.
16. Utrecht J.P., Trager W.F. Drug Metabolism - Chemical and Enzymatic Aspects 2007, Informa, New York.
17. Rendic S. Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab. Rev. 2002, 34:83-448.
18. Pelkonen O. Human CYPs: in vivo and clinical aspects. Drug Metab. Rev 2002, 34:37-46.
19. Testa B., Soine W. Principles of drug metabolism. Burger's Medicinal Chemistry and Drug Discovery, 6th Edition 2003, Volume 2:431-498. Wiley-Interscience, Hoboken, NJ. D.J. Abraham (Ed.).
20. Testa B., Krämer S.D. The biochemistry of drug metabolism-An introduction. Part 1: Principles and overview. Chem. Biodiver. 2006, 3:1053-1101.
21. Trager, W. F. Principles of drug metabolism 1: Redox reactions. In ADME-Tox Approaches (Testa, B., van de Waterbeemd, H., Eds.), Vol. 5. In Comprehensive Medicinal Chemistry (Taylor, J. B., Triggle, D. J., Eds.), 2nd Edition. Elsevier: Oxford, 2007, pp. 87-132.
22. Testa, B. Principles of drug metabolism 2: Hydrolysis and conjugation reactions. In ADME-Tox Approaches (Testa, B., van de Waterbeemd, H., Eds.), Vol. 5. In Comprehensive Medicinal Chemistry (Taylor, J. B., Triggle, D.J., Eds.), 2nd Edition. Elsevier: Oxford, 2007, pp. 133-166.
23. Testa B., Krämer S.D. The biochemistry of drug metabolism - an introduction. Part 2: Redox reactions and their enzymes. Chem. Biodiver. 2007, 4:257-405.
24. Testa B., Krämer S.D. The biochemistry of drug metabolism - an introduction. Part 3: Reactions of hydrolysis and their enzymes. Chem. Biodiver. 2007, 4:2031-2122.
25. Walle T., Walle U.K., Olanoff L.S. Quantitative account of propranolol metabolism in urine of normal man. Drug Metab. Dispos. 1985, 13:204-209.
26. Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB). Enzyme Nomenclature (). http://www.chem.qmul.ac.uk/iubmb/enzyme.
27. Nelson D.R., Zeldin D.C., Hoffman S.M.G., Maltais L.J., Wain H.M., Nebert D.W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative splice variants. Pharmacogenetics 2004, 14:1-18.
28. Nelson, D. R. Cytochrome P450 homepage (. http://www.drnelson.utmem.edu/CytochromeP450.html.
29. Directory of P450-containing Systems. (). http://www.icgeb.org/~p450srv/.
30. Brenda: The Comprehensive Enzyme Information System. (). http://www.brenda.unikoeln.de.
31. ExPASy Proteomics Server (). http://www.expasy.org.
32. Rambeck B., May T., Juergens U. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication. Ther. Drug Monit. 1987, 9:298-303.
33. Jindal S.P., Lutz T. Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labeled analogues. J. Pharmacol. Sci. 1989, 78:1009-1014.
34. Brzezinski M.R., Spink B.J., Dean R.A., Berkman C.E., Cashman J.R., Bosron W.F. Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab. Dispos. 1997, 25:1089-1096.
35. Reist M., Carrupt P.A., Francotte E., Testa B. Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites. Chem. Res. Toxicol. 1998, 11:1521-1528.
36. Lu J., Helsby N., Palmer B.D., Tingle M., Baguley B.C., Kestell P., Ching L.M. Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans. J. Pharmacol. Exp. Ther. 2004, 310:571-577.
37. Testa B., Krämer S.D. The biochemistry of drug metabolism - an introduction. Part 4: Reactions of conjugation and their enzymes. Chem. Biodiver. 2008, in press.
38. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 1999, 39:19-52.
39. Ginsberg G., Hattis D., Russ A., Sonawane B. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents. J. Toxicol. Environ. Health A 2004, 67:297-329.
40. Nagata K., Yamazoe Y. Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol. Tox. 2000, 40:159-176.
41. Banoglu E. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab. 2000, 1:1-30.
42. Kauffman F.C. Sulfonation in pharmacology and toxicology. Drug Metab. Rev. 2004, 36:823-843.
43. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40:581-616.
44. Fisher M.B., Paine M.F., Strelevitz T.J., Wrighton S.A. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab. Rev. 2001, 33:273-297.
45. Bock K.W. Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. Biochem. Pharmacol. 2003, 66:691-696.
46. Maruo Y., Iwai M., Mori A., Sato H., Takeuchi Y. Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Curr. Drug Metab. 2005, 6:91-99.
47. Milne R.W., Nation R.L., Somogyi A.A. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab. Rev. 1996, 28:345-472.
48. Spahn-Langguth H., Benet L.Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?. Drug Metab. Rev. 1992, 24:5-48.
49. Grant D.M., Blum M., Meyer U.A. Polymorphisms of N-acetyltransferase genes. Xenobiotica 1992, 22:1073-1081.
50. Agundez J.A.G., Olivera M., Martinez C., Ladero J.M., Benitez J. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 1996, 6:423-428.
51. Kawamura A., Graham J., Mushtaq A., Tsiftsoglou S.A., Vath G.M., Hanna P.E., Wagner C.R., Sim E. Eukaryotic arylamine N-acetyltransferase: investigation of substrate specificity by high-throughput screening. Biochem. Pharmacol. 2005, 69:347-359.
52. Knights K.M., Drogemuller C.J. Xenobiotic-CoA ligases: kinetics and molecular characterization. Curr. Drug Metab. 2000, 1:49-66.
53. Kasuya F., Igarashi K., Fukui M. Participation of a medium chain acyl-CoA synthetase in glycine conjugation of the benzoic acid derivatives with the electron-donating groups. Biochem. Pharmacol. 1996, 51:805-809.
54. Brugger R., Reichel C., Garcia Alia B., Brune K., Yamamoto T., Tegeder I., Geissinger G. Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. Biochem. Pharmacol. 2001, 61:651-656.
55. Mayer J.M., Testa B. Pharmacodynamics, pharmacokinetics and toxicity of ibuprofen enantiomers. Drug. Fut. 1997, 22:1347-1366.
56. Gopaul V.S., Tang W., Farrell K., Abbott F.S. Amino acid con-jugates: metabolites of 2-propylpentanoic acid (valproic acid) in epileptic patients. Drug Metab. Dispos. 2003, 31:114-121.
57. Sies H. Glutathione and its role in cellular functions. Free Rad. Biol. Med. 1999, 27:916-921.
58. Dickinson D.A., Forman H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002, 64:1019-1026.
59. Pompella A., Visvikis A., Paolicchi A., De Tala V., Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochem. Pharmacol. 2003, 66:1499-1503.
60. Hayes J.D., Pullford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30:445-600.
61. Armstrong R.N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 1997, 10:2-18.
62. Sheenan D., Meade G., Foley V.M., Dowd C. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360:1-16.
63. Jowsey I.R., Thomson A.M., Flanagan J.U., Murdock P.R., Moore G.B.T., Meyer D.J., Murphy G.J., Smith S.A., Hayes J.D. Mammalian class sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem. J. 2001, 359:507-516.
64. Schnekenburger M., Morceau F., Duvoix A., Delhalle S., Trentesaux C., Dicato M., Diederich M. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells. Biochem. Pharmacol. 2004, 68:1269-1277.
65. Ketterer B. The role of nonenzymatic reactions of glutathione in xenobiotic metabolism. Drug Metab. Rev. 1982, 13:161-187.
66. Monks T.J., Lau S.S. Biological reactivity of polyphenolic-glutathione conjugates. Chem Res. Toxicol. 1997, 10:1296-1313.
67. Anders M.W. Glutathione-dependent bioactivation of haloalkanes and haloalkenes. Drug Metabol. Rev. 2004, 36:583-594.
68. Totah, R. A., Rettie, A. E. Principles of drug metabolism 3: Enzymes and tissues. In ADME-Tox Approaches (Testa, B., van de Waterbeemd, H., Eds.), Vol. 5. In Comprehensive Medicinal Chemistry (Taylor, J. B., Triggle, D. J., Eds.), 2nd Edition. Elsevier: Oxford, 2007, pp. 167-191.
69. Krämer S.D., Testa B. The biochemistry of drug metabolism - an introduction. Part 6: Inter-individual factors affecting drug metabolism. Chem. Biodiver. 2008, in press.
70. Krämer S.D., Testa B. The biochemistry of drug metabolism - an introduction. Part 7: Intra-individual factors affecting drug metabolism. Chem. Biodiver. 2008, 16. in press.